Search Videos and More

Showing 13 - 24 of 50 results

Previous| 1 | 2 | 3 ...5 |Next


Season 2, Episode 2: Thalidomide and its Second Act in Multiple Myeloma Podcast

Season 2, Episode 2: Thalidomide and its Second Act in Multiple Myeloma

Momentum isn't always one way. And it's not always constant. Sometimes it shoves you sideways, sometimes it stops you in your tracks. And sometimes only sometimes, it drives you to write one of the most astonishing second acts in all of medicine. That's the story of thalidomide.
Smoldering Multiple Myeloma - A Unique New Approach Video

Smoldering Multiple Myeloma - A Unique New Approach

When Deidre was diagnosed with a precursor condition to multiple myeloma she enrolled in a brand-new clinical trial being conducted at Dana-Farber Cancer Institute. Deidre and her doctor, Dana-Farber's Irene Ghobrial, MD, explain more in this video.
Dana-Farber Led Study Leads to FDA Approval for Next-Generation Drug in Relapsed Chronic Lymphocytic Leukemia News

Dana-Farber Led Study Leads to FDA Approval for Next-Generation Drug in Relapsed Chronic Lymphocytic Leukemia

On Thursday, January 19, 2023, the FDA approved zanubrutinib, a next-generation BTK inhibitor for the treatment of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
For Older Patients with Blood Cancer Taking Multiple Medications, New Tool Links Use of Certain Medications to Risk of Frailty News

For Older Patients with Blood Cancer Taking Multiple Medications, New Tool Links Use of Certain Medications to Risk of Frailty

A new tool developed by researchers at Dana-Farber Cancer Institute and Brigham and Women's Hospital outperforms conventional methods for predicting whether certain medications are likely to lead to frailty in older patients with blood cancers who are taking multiple medications, a study being published online today indicates.
In Memoriam: Arthur T. Skarin, MD, Physician-Scientist Instrumental in Building Dana-Farber’s Adult Oncology Program News

In Memoriam: Arthur T. Skarin, MD, Physician-Scientist Instrumental in Building Dana-Farber’s Adult Oncology Program

The Dana-Farber community mourns the passing of Arthur T. Skarin, MD, of Needham, Massachusetts.
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Video

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Inhye Ahn, MD, discusses the background and management of chronic lymphocytic leukemia and small lymphocytic lymphoma.
Hodgkin Lymphoma Video

Hodgkin Lymphoma

Ann LaCasce, MD, MMSc, discusses Hodgkin lymphoma and how to approach the different types of Hodgkin patients.
CAR-T Cell Therapy for Lymphoma: Updates and Progress Video

CAR-T Cell Therapy for Lymphoma: Updates and Progress

Caron Jacobson, MD, MMSc, gives updates and shares progress with CAR-T cell therapy for lymphoma.
Hematologic Malignancies CME: 2021 Symposium

Hematologic Malignancies CME: 2021

The care of patients with hematologic malignancies is evolving rapidly. These video highlights discuss new developments in the diagnosis and treatment of hematologic malignancies presented at the 2021 Annual Meeting of the American Society of Hematology (ASH).
Blood Cancer Research: Clinical Trial Helps Younger Patient Video

Blood Cancer Research: Clinical Trial Helps Younger Patient

A patient shares her journey getting diagnosed with chronic lymphocytic leukemia in her 30's. Dana-Farber Cancer Institute's Matthew Davids, MD, MMSc, enrolled her on a clinical trial and details the results of that study. The research is now getting presented at ASH21.
ASH 2021 Highlights - CME News

ASH 2021 Highlights - CME

Register for 2021 ASH Highlights CME
New Study Reveals Elevated Rates of Blood Cancer Precursor Condition in Groups at High Risk for Multiple Myeloma Video

New Study Reveals Elevated Rates of Blood Cancer Precursor Condition in Groups at High Risk for Multiple Myeloma

Dana-Farber Cancer Institute research shows elevated rates of a blood cancer precursor condition in groups at high risk for multiple myeloma.

Showing 13 - 24 of 50 results

Previous| 1 | 2 | 3 ...5 |Next